CGS-CIMB's Tay expects Raffles Medical's operating margins to 'normalise' at a level higher than before the pandemic CGS-CIMB's Tay Wee Kuang has reiterated his 'add' call on Raffles Medical Group Bsl ...

CIMB Research raised its target price on shares of Raffles Medical Group Ltd to S$3.52 from S$2.96 and kept its 'outperform' rating, as it expects the healthcare provider to see operating efficiency.

Raffles Medical is Maybank’s preferred pick in the healthcare sector. Analysts at CGS-CIMB Research, Maybank Securities and RHB Bank Singapore have kept their “add” and “buy” calls on Raffles Medical ...

PETALING JAYA: The valuation of CIMB Group Holdings Bhd may get a boost from its Singapore operations that have made a significant turnaround after having impaired oil and gas as well as marine sector ...

CIMB’s Singapore business had a standout year in 2024 in terms of making its strategic investments in technology and digital transformation pay off – through deeper customer engagement, enhanced ...